Published on in Vol 22, No 5 (2020): May
1 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
2 Department of Neurology, Multiple Sclerosis Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands
3 Novartis Pharma AG, Basel, Switzerland
4 Neurocenter, Luzerner Kantonsspital, Luzern, Switzerland
5 Department of Neurology, Inselspital, University of Bern, Bern, Switzerland
6 Microsoft Research, Cambridge, United Kingdom
*these authors contributed equally